0001681682 1 2026-03-30 2026-03-30 0001681682 2026-03-30 2026-03-30 iso4217:USD pure shares S-8 EX-FILING FEES 0001681682 false N/A S-8 ENDRA Life Sciences Inc. Equity Common Stock, $0.0001 par value per share, to be issued under the Registrant's 2016 Omnibus Incentive Plan true 3200000 5.0325 16104000.00 0.0001381 2223.97 16104000.00 2223.97 0.00 2223.97 1a. Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers such indeterminate number of additional shares of the Registrant’s common stock (“Common Stock”) as is necessary to eliminate any dilutive effect of any future stock split, stock dividend or similar transaction.<br/><br/>1b. Proposed Maximum Offering Price Per Unit is estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act and based on the average of the high and low prices for the Registrant’s Common Stock on May 11, 2026, as reported on The Nasdaq Capital Market.<br/><br/>1c. Represents 3,200,000 additional shares of Common Stock reserved for future issuance under the Registrant’s 2016 Omnibus Incentive Plan, as amended by the Second Amendment effective December 9, 2025.